Abstract
Background
We evaluated whether patients' initial screening symptoms were related to subsequent utilization of supportive care services and hospitalizations, and whether patient‐level demographics, symptoms, hospitalizations, and supportive care service utilization were associated with mortality in primarily low‐income, older, Black Veterans with cancer.
Methods
This quality improvement project created collaborative clinics to conduct cancer distress screenings and refer to supportive care services at an urban, VA medical center. All patients completed a distress screen with follow‐up screening every 3 months. Supportive care utilization, hospitalization rates, and mortality were abstracted through medical records. Poisson regression models and cox proportional hazard models were utilized.
Results
Five hundred and eighty five screened patients were older (m = 72), mostly Black 70% (n = 412), and had advanced cancer 54%. Fifty‐eight percent (n = 340) were screened only once with 81% (n = 470) receiving ≥1 supportive care service and 51.5% (n = 297) being hospitalized ≥1 time 18 months following initial screen. Symptom severity was significantly related to number of hospitalizations. Low mood was significantly related to higher supportive services (p < 0.001), but not hospitalizations (p ≥ 0.52). Pain, fatigue, physical function, nutrition, and physical symptoms were significantly associated with more supportive services and hospitalizations (p < 0.01). Twenty percent (n = 168) died; Veterans who were Black, had lower stage cancers, better physical health, and utilized less supportive care services had lower odds of mortality (p ≤ 0.01).
Conclusion
Individuals with elevated distress needs and those reporting lower physical function utilized more supportive care services and had higher hospitalization rates. Lower physical function, greater supportive care use, higher stage cancer, and being non‐Black were associated with higher odds of death.
Keywords: Black Veterans, distress screening, hospitalization, mortality, oncology, psycho‐oncology, supportive care services
1. INTRODUCTION
Cancer diagnosis and treatment result in significant distress and supportive care needs for almost 50% of patients. 1 Undertreated symptoms often result in worse patient outcomes including hospitalizations and mortality. 2 , 3 Veterans can be at increased risk for uncontrolled symptoms during their cancer trajectory due to having higher comorbidities (e.g., physical debility and post‐traumatic stress disorder). 4 , 5 , 6 , 7 Underrepresented minorities and older adults also face greater inequities having less access to medical care, lower health literacy, greater financial barriers, and higher rates of comorbid conditions. 4 , 8 , 9 , 10 , 11 Identifying individuals at greatest risk for worse cancer outcomes remains relevant for patients, providers, health care systems, and payers alike and can help to illuminate intervention targets. 12
In 2012, the National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) established standards for distress screening and supportive care service referrals in oncology to address distress‐related needs and improve cancer outcomes. 13 , 14 , 15 , 16 Implementation and maintenance of distress screening programs vary in their make‐up, with most programs using modifications of existing protocols to match the unique needs of the population at hand, resulting in variable success. 1 , 17 , 18 , 19 , 20 Studies that implemented distress screening and patient‐reported outcome programs demonstrate improved symptom detection, 4 hospitalization prevention, 21 and better connections to supportive care services, 3 , 22 and can result in increased referrals and utilization of outpatient supportive care services, and reduced hospitalizations. 23 , 24 Providing connections to supportive care services is important to help resolve distress during cancer; however, several barriers to successful supportive care visits have been identified (e.g. lack of insurance coverage). 12 , 25 Integrated interdisciplinary care models may be more effective at delivering supportive care services, particularly within closed health care systems with accessible supportive care services (e.g. Veterans Affairs [VA] Healthcare systems) 25 , 26 ; Yet, evaluation of such programs is lacking. Most evaluations of distress screening programs have been conducted in affluent, primarily White, NCI‐designated cancer centers, with fewer reports of screening programs and their outcomes in community clinics or those serving primarily underrepresented minorities. 9 , 22 , 24
In response to the NCCN mandate, the Coleman Supportive Oncology Collaborative 1 (CSOC), funded 25 Chicago‐area cancer care institutions to implement distress screening and develop agreed‐upon standards of care. The Jesse Brown VA Medical Center was chosen to evaluate cancer‐related concerns and improve access to supportive oncology. We previously published distress screening findings of our interdisciplinary, supportive care quality improvement (QI) initiative including feasibility of the primary project with screening rates, distress prevalence, 10 and descriptions of the program's palliative care integration process within outpatient oncology 27 in this mostly Black, older cohort of male Veterans. With the completion of the program's implementation cycles (2017–2020), we prospectively evaluated the associations between distress screening, subsequent supportive care utilization, hospitalization, and mortality in this underserved sample. We evaluated (1) whether patients' initial screening symptoms were related to subsequent utilization of supportive care services and hospitalizations and (2) whether patient‐level demographics, symptoms, hospitalizations, and supportive care service utilization were associated with mortality in this underserved population.
2. METHODS
2.1. Program, setting, and participants
The Jesse Brown VA serves 49,000 unique Veterans each year including predominately Black men of low socioeconomic status (SES) in Chicago, Cook County, IL. At Jesse Brown VA, patients receive care through four separate, half‐day general outpatient hematology‐oncology clinics, staffed by attendings and hematology/oncology fellows from two affiliated academic medical centers. In response to the NCCN/ACOS Commission on Cancer mandate 3.2 (now 5.2 in the 2020 standards), 28 the grant was awarded to the Jesse Brown VA with a key emphasis on improving supportive oncology by increasing interdisciplinary team collaboration and supporting linkage across service lines through inter‐departmental supportive care referrals within the VA healthcare system. To do so, the project supported creation of a quality improvement team including a palliative care physician, palliative care advanced practice nurse, and psychology interns. The project supported integration of a QI team member within the outpatient general hematology‐oncology clinics to deliver screenings, evaluate patients' supportive care needs, and collaborate with oncology clinicians to refer patients to appropriate supportive care. Screening was first implemented within two clinics in the first 15 months of implementation and later expanded to a third clinic following additional staffing and after procedures were refined. In the participatory clinics, screening was offered to all Veterans with malignant cancer diagnoses and/or a new cancer diagnosis. The QI team member, prior to their assigned clinic, needed to predetermine and follow which patients qualified for screening as these were general hematology‐oncology clinics also serving patients with non‐malignant issues. In clinics with embedded QI team members, veterans could be flagged for an individual assessment either by the results of their completed screen or by referral from a medical oncology physician. 10 , 27
Ethical approval was received from the Institutional Review Board of the Jesse Brown VA as a QI Project (SQUIRE‐guidelines); not requiring written informed consent (GCL#21270). 29 This project was implemented between January 2017–January 2020. Methods for complete program development and initial findings are reported elsewhere. 10
2.2. Screening instrument and clinical procedures
Veterans receiving care for a new diagnosis and/or oncology‐related needs at the Jesse Brown VA completed a distress screening during program initiation. All veterans completed screening, unless unable to read or unwilling to do so. Follow‐up screening occurred at 3‐month intervals. Veterans completed paper‐form screening as they awaited being seen by their oncologists, and returned the form to the triage nurse, who then shared them with the patients' treating oncologist. The QI team reviewed the screening results for elevated symptoms (previously identified cut‐offs; see measure references respectively). Oncology fellows were trained by the QI team before program initiation to discuss relevant needs with the patient, or to conduct a “warm hand‐off” to the QI team to complete the clinical evaluation. Appropriate referrals for supportive care services were then placed by either the oncology fellow or QI team. To assist with referral initiation, the QI team created and distributed a referral action guide for internal supportive oncology referrals in each clinic room. Supportive care services identified as relevant to oncology needs included outpatient palliative care, social work, pain management, mental health, chaplaincy, and nutrition services. Distress screening and treatment integration occurred within one physical space with co‐located QI team members functioning in unison with oncology staff (physicians, nurses, and administrative staff), allowing real‐time discussion between oncology staff (attendings, fellows, nurses) and the QI team members to review clinical evaluations and subsequent referrals to address patients' needs. Previous analyses identified that 25–50% of all new consults and similar rates of current patients were screened 10 , 27 ; Patients were not screened because they either had primary hematologic concerns, were not receiving their primary treatment through the VA, denied screening often because they denied symptoms/needs, or because they were missed during an appointment time. For patients with elevated psychosocial needs, 36% were connected with psychosocial services before screening and 77% were connected with psychosocial care after screening. 10
The study utilized the “Patient Screening Questions for Supportive Care” developed by an interdisciplinary group of 35 organizations through the CSOC. 30 This measure includes a compilation of validated measures combined for this QI program (10 min to complete). 10 The screening questionnaire included: the NCCN Guidelines Distress Management Needs Assessment Problem List‐ Physical and Other Concerns (number of “physical symptoms”; 20 total e.g., breathing, constipation, fevers, skin issues, substance use), 31 and Practical Concerns (e.g., issues paying for food, housing, transportation, insurance coverage), the Patient‐Reported Outcomes Measurement Information System (PROMIS) 32 : Pain Intensity (3a, 10‐point Likert scale), Fatigue‐SF (4‐item; 5‐point Likert scale), and Physical Function (5‐item; e.g. go up and down stairs, able to get out of bed; 5‐point Likert scale) subscales, the Mini Nutrition Assessment short‐form (MNA‐SF; binary responses yes/no; concerns for weight loss/gain and issues with taste and food), 33 and the Patient Health Questionnaire (PHQ)‐4 (symptoms of anxiety and depression; 4‐point Likert scale; scoring: 0–4 = none/minimal, 5–9 = mild, 10–14 = moderate, 15–19 = moderately severe, 20–27 severe). 34 For all measures, higher scores represent higher rates of that symptom, except physical function where higher scores indicate worse physical function.
Relevant data were extracted from the medical record with a censorship date of 18 months from initial screen. A trained research assistant (F.S.) abstracted demographic data, mortality status and date, hospitalizations, and supportive care service utilization. Due to medical record limitations as the system does not track this data, we were unable to evaluate whether each service visit was directly related to a distress screen referral; however, we only abstracted supportive care services that occurred after the patients' initial screening date. Our previous analysis identified that very few patients received supportive care services at the start of this program. 10
2.3. Statistical analysis
Patients with cancer who had completed at least one distress screen were included in analyses. We used two separate univariate Poisson regression models with robust standard errors to evaluate the association of symptom severity at screen 1 for symptoms (independent variables) of (1) pain, (2) depression, and (3) fatigue, (4) levels of physical function, (5) rates of physical symptoms, (6) nutrition concerns, and (7) practical concerns with the dependent variables: number of supportive care services and number of hospitalizations; For practical concerns, the variable responses had 48% zero values and limited variability above 0, a binary logistic regression model (i.e., the response was 0 vs. >0) was utilized instead.
Cox proportional multivariable hazard model was utilized to evaluate the association of age, race, cancer stage, list of symptoms, number of hospitalizations, and number of supportive care services with time to death (dependent variable). Variables including age, number of hospitalizations, symptoms of pain, depression, and fatigue, rates of physical symptoms, practical concerns, and nutritional concerns were removed from the multivariable analysis because Pearson's correlations were greater than 0.90 with other model variables. Analyses were performed in SAS 9.3 (SAS Institute).
3. RESULTS
In total, 585 patients were successfully screened once or more for distress during their outpatient oncology care (1 screen, n = 585; 2 screens [42.2%]; 3 screens [18.1%]; 4 screens [8.3%]; 5 screens [2.4%]; 6 screens [1.5%]). Patients were 72 years old on average (SD = 9.5), mostly male (96%), Black (70%), had advanced‐stage cancer (for all solid organ tumors, except prostate, stage III/IV = 53.6%); with 213 missing or un‐staged hematologic or prostate cancers, and reported mild depressive/anxiety symptoms (PHQ‐4 m = 2.49 [SD = 3.165]). At initial screening, patients reported elevated symptoms of pain, fatigue, and physical function [Pain m = 57.3, SD = 1.9 (t‐score), Fatigue m = 50.8, SD = 2.5 (T‐score), Physical Function m = 19.0, SD = 5.5(T‐score)]. More than half of the patients reported elevated rates of physical concerns [≥4 = 61%], 52% reported practical concerns for paying for food, housing, transportation, or work‐related needs, and 54% reported nutrition concerns. Evidence of the program's success, most patients were seen by one or more supportive care services in the 18 months following their initial distress screen (81.2%). About half of the sample was hospitalized at least once in the 18 months following their initial distress screen (52.8%), with 29.4% being hospitalized at least 2 or more times, and a quarter of the sample died within 18 months of their initial screen (26.8%). See Table 1.
TABLE 1.
Patient demographics who completed distress screen during outpatient oncology visits (n = 585)
| Variable | n (%) | M (SD) |
|---|---|---|
| Age | 71.78 (9.50) | |
| Stage | ||
| I | 54 (14.6) | |
| II | 45 (12.2) | |
| III | 74 (20) | |
| IV | 197 (53.6) | |
| Unstaged/unknown | 215 (36.7) | |
| Cancer type | ||
| Lung | 125 (21.6) | |
| Prostate | 97 (16.8) | |
| Breast | 56 (9.7) | |
| Multiple Myeloma | 47 (8.1) | |
| ENT | 33 (5.7) | |
| Lymphoma | 33 (5.7) | |
| Leukemia | 29 (5.0) | |
| Colorectal | 27 (4.7) | |
| Gastric | 24 (4.2) | |
| Renal | 19 (3.3) | |
| Pancreatic | 17 (2.9) | |
| Urinary | 12 (2.1) | |
| Hepatocellular | 11 (1.9) | |
| Other | 44 (7.6) | |
| Race | ||
| Black | 412 (70.3) | |
| White | 137 (23.4) | |
| Other | 9 (1.6) | |
| Number of hospitalizations | ||
| 0 | 281 (48.6) | |
| 1 | 127 (22.0) | |
| 2 | 74 (12.8) | |
| 3 | 45 (7.8) | |
| 4 | 16 (2.8) | |
| ≥5 | 35 (6.1) | |
| Number of supportive care services utilized in18 months following screening | ||
| None | 109 (18.8) | |
| 1 | 108 (18.7) | |
| 2 | 79 (13.6) | |
| 3 | 64 (11.1) | |
| 4 | 45 (7.8) | |
| 5 | 56 (9.7) | |
| 6 | 73 (12.6) | |
| ≥7 | 45 (7.8) | |
| Rates of supportive care services | ||
| Palliative care | 158 (27.3) | |
| Nutrition | 307 (53.0) | |
| Social work | 363 (62.7) | |
| Psychology | 72 (12.5) | |
| Psychiatry | 119 (20.6) | |
| Physical therapy | 255 (44.0) | |
| Occupational therapy | 195 (33.7) | |
| Pain clinic | 27 (4.7) | |
| Chaplaincy | 185 (32.0) | |
| Mortality w/in 18 months from screening | 168 (26.8) | |
3.1. Association of initial symptom severity with no. of subsequent supportive care services and hospitalizations
Symptoms of depression/anxiety (9% increase, p ≤ 0.001), pain (5% increase, p ≤ 0.0001), fatigue (5% increase, p ≤ 0.001), physical symptoms (7% increase, p ≤ 0.0001), and nutritional concerns (11% increase, p ≤ 0.0001) during their initial screen were associated with significant increases in the number of utilized supportive care services. For individuals with improved physical function, this was associated with a 4% decrease (p ≤ 0.0001) in the number of supportive care services across participants (Table 2A). Similarly, for individuals with increased symptoms of pain (3% increase, p = 0.013) and fatigue (3% increase, p = 0.002), higher numbers of physical symptoms (4% increase, p = 0.017) and nutrition concerns (6% increase, p = 0.015) was significantly associated with more hospitalizations, but symptoms of anxiety/depression and practical concerns were not associated with significantly greater hospitalizations. For individuals with improved physical function, this was associated with a 3% decrease (p ≤ 0.0001) in the number of hospitalizations across the sample (Table 2B).
TABLE 2.
The association of symptom severity with number of supportive care services and number of hospitalizations using poisson regression models
| A. The association of symptom severity with number of supportive care services | ||||
|---|---|---|---|---|
| Estimate | Robust standard error | p | Incident rate ratios (IRR) | |
| Depression/anxiety | 0.0826 | 0.0222 | ≤ 0.001 | 1.09 (1.04, 1.13) |
| Pain | 0.0491 | 0.0091 | ≤ 0.0001 | 1.05 (1.03, 1.07) |
| Fatigue | 0.0521 | 0.0083 | ≤ 0.001 | 1.05 (1.04, 1.07) |
| Physical function | −0.0419 | 0.0051 | ≤ 0.0001 | 0.96 (0.95, 0.97) |
| Physical symptoms | 0.0698 | 0.0129 | ≤ 0.0001 | 1.07 (1.05, 1.10) |
| Nutrition concerns | 0.1088 | 0.0210 | ≤ 0.0001 | 1.11 (1.07, 1.16) |
| Odds ratio estimate | 95% CI | p | ||
|---|---|---|---|---|
| Practical concerns | 1.047 | (0.977, 1.122) | 0.19 |
| B. The association of symptom severity with number of hospitalizations | ||||
|---|---|---|---|---|
| Estimate | Robust standard error | p | Incident rate ratios (IRR) | |
| Depression/anxiety | 0.0187 | 0.0288 | 0.52 | 1.02 (0.96, 1.08) |
| Pain | 0.0325 | 0.0130 | 0.013 | 1.03 (1.01, 1.06) |
| Fatigue | 0.0289 | 0.0091 | 0.002 | 1.03 (1.01, 1.05) |
| Physical function | −0.0327 | 0.0084 | ≤ 0.0001 | 0.97 (0.95, 0.98) |
| Physical symptoms | 0.0362 | 0.0152 | 0.017 | 1.04 (1.01, 1.07) |
| Nutrition concerns | 0.0564 | 0.0231 | 0.015 | 1.06 (1.01, 1.11) |
| Odds ratio estimate | 95% CI | p | ||
|---|---|---|---|---|
| Practical concerns | 0.995 | (0.913, 1.085) | 0.91 |
Note: *p‐value calculated from maximum likelihood estimates. PHQ‐4: depressive/anxiety symptoms. Depression and anxiety: PHQ4. Physical function: PROMIS Physical function. Physical symptoms: NCCN checklist. Nutrition concerns: MNA‐SF.
3.2. Associations with mortality
In univariable analyses, patients who were older or White, had stage 4 cancer, had higher utilization of supportive care services, increased hospitalizations, and self‐reported higher symptoms of depression/anxiety, pain, and fatigue, lower physical function, increased physical symptoms, practical concerns, and nutrition concerns had significantly higher odds of mortality at 95% confidence limit (p ≤ 0.05, Table 3). After removing the variables with elevated multicollinearity in the multivariable model (See Appendix A), we found that compared to patients with stage 0 or 1 cancers, the risk of death was 3 times higher [Hazard Ratio (HR): 3.0, CI:1.43–6.33, p = 0.004] for patients with stage 4 cancers (Table 4). Compared to non‐Black participants, the risk of death decreased by 38% (HR:0.62, CI:0.39–0.98, p = 0.041) for Black patients. For each increase in utilized supportive care services, the risk of death increased by 11% (HR:1.11, CI:1.01–1.23, p = 0.028). For each one‐unit increase in Physical Function, the risk of death decreased by 9% (HR: 0.91, CI:0.87–0.94, p < 0.001).
TABLE 3.
The associations of age, list of symptoms, number of hospitalizations and number of supplemental services with time to death using univariable Cox proportional hazards regression models
| Parameter | Total | No. of events | Estimate | Standard error | p‐value | Hazard ratio (HR) |
|---|---|---|---|---|---|---|
| Age | 574 | 164 | 0.0141 | 0.00834 | 0.093 | 1.01 (0.99–1.03) |
| No. of supportive care services | 574 | 164 | 0.2482 | 0.0337 | ≤ 0.0001 | 1.28 (1.20–1.37) |
| No. of hospitalization | 573 | 164 | 0.0865 | 0.0317 | 0.006 | 1.09 (1.03–1.16) |
| Depression/anxiety | 530 | 145 | 0.0874 | 0.0240 | ≤ 0.0.001 | 1.09 (1.04–1.14) |
| Pain | 427 | 130 | 0.0636 | 0.0245 | 0.009 | 1.07 (1.02–1.12) |
| Fatigue | 535 | 148 | 0.0958 | 0.0168 | ≤0.0001 | 1.10 (1.07–1.14) |
| Physical function | 523 | 146 | −0.1133 | 0.0146 | ≤0.0001 | 0.89 (0.87–0.92) |
| Physical symptoms | 580 | 164 | 0.0591 | 0.0195 | 0.002 | 1.06 (1.02–1.10) |
| Practical concerns | 580 | 164 | −0.0734 | 0.0658 | 0.26 | 0.93 (0.82–1.06) |
| Nutritional concerns | 580 | 164 | 0.0868 | 0.0256 | ≤0.0.001 | 1.09 (1.04–1.15) |
| Stage | ||||||
| 2 | 369 | 114 | 0.38301 | 0.48592 | 0.4306 | 1.47 (0.57–3.80) |
| 3 | 369 | 114 | 0.23742 | 0.44936 | 0.5973 | 1.27 (0.53–3.06) |
| 4 | 369 | 114 | 1.33484 | 0.37038 | 0.0003 | 3.80 (1.84–7.85) |
| 0 or 1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Race | ||||||
| Black | 554 | 152 | −0.1941 | 0.1779 | 0.2755 | 0.82 (0.58–1.17) |
| Non‐Black | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Note: *Depression and anxiety: PHQ4. Physical function: PROMIS Physical function. Physical symptoms: NCCN checklist. Nutrition concerns: MNA‐SF.
TABLE 4.
The association of cancer stage, race, symptoms, no. of supportive care services with time to death using a multivariable Cox proportional hazards regression model
| Parameter | Parameter estimate | Standard error | Chi‐Square | p | Hazard ratio | 95% Hazard ratio confidence limits | |
|---|---|---|---|---|---|---|---|
| Physical function | −0.09847 | 0.01942 | 25.7191 | <0.0001 | 0.906 | 0.872 | 0.941 |
| Supportive care service utilization | 0.10760 | 0.04889 | 4.8440 | 0.0277 | 1.114 | 1.012 | 1.226 |
| Stage | |||||||
| Stage 0/1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Stage 2 | 0.22504 | 0.50324 | 0.2000 | 0.6547 | 1.252 | 0.467 | 3.358 |
| Stage 3 | −0.10056 | 0.48818 | 0.0424 | 0.8368 | 0.904 | 0.347 | 2.354 |
| Stage 4 | 1.10155 | 0.37904 | 8.4459 | 0.0037 | 3.009 | 1.431 | 6.325 |
| Race | |||||||
| Black | −0.48157 | 0.23585 | 4.1691 | 0.0412 | 0.618 | 0.389 | 0.981 |
| Non‐Black | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Note: *Variables including age, number of hospitalizations, PHQ4, PROMIS Pain, PROMIS Fatigue, Physical Symptoms, number of practical concerns, nutritional concerns were removed from the multivariable analysis as they surpassed multicollinearity cutoffs, Pearson's correlation ≥0.90 with other variables, see Appendix A. Physical function: PROMIS Physical function.
4. DISCUSSION
The results of this prospective, longitudinal QI project in a sample of 585 primarily older, Black, male Veterans at an urban VA medical Center, identified that patient‐reported factors and unmet needs were significantly associated with higher rates of subsequent supportive care service utilization, hospitalizations, and mortality. Within 18 months following an initial distress screen, 81% of patients were seen by one or more supportive care services, 52% had been hospitalized at least once, and 27% had died. Elevated patient‐reported needs during initial distress screening were significantly associated with the number of supportive care services utilized and number of hospitalizations. Notably, patient‐reported symptoms including psychological symptoms were related to mortality on univariable analysis, yet in multivariable models, individuals who were Black and those who were more physically fit had lower odds of death, and those with worse stage cancers or who utilized more supportive care services had higher odds of death.
Our previous paper outlining distress rates confirmed that this study sample reported higher rates of undertreated needs in this VA sample compared to general U.S. samples. 10 While our findings parallel previous observations that increased distress and undertreated physical and practical needs were related to increased supportive care service utilization, 3 , 35 this study identified that in a sample of mostly male Veterans who face distinctive challenges given their prolonged exposure to trauma, chronic health comorbidities, and elevated financial needs, individuals utilize services at higher rates compared to other samples. 8 , 35 , 36 Encouragingly, these findings provide further validity for the association between distress screening and subsequent supportive care service utilization. Findings also provide distinct rates of supportive care service utilization following screening, expanding on Van Ryn et al.'s 2014 national survey of Veterans that identified non‐White patients were more likely to receive the help that they wanted during their cancer care compared to their white counterparts. 4 Our findings also support previous theories that the Veteran's Health Administration's focus on reducing racial disparities in care may be succeeding. 4 , 37 It may also be the case that individuals were more likely to engage in supportive care services because these services are often covered within VA care and do not result in substantially increased costs; this difference may be especially noticeable as rates of financial toxicities from cancer continue to increase. 9 , 38 The results highlight that integration of distress screening through interdisciplinary care coordination served to identify elevated symptoms which were associated with increased supportive care service utilization in this group of mostly older, Black, male Veterans with cancer.
Multivariable analysis identified that odds of mortality were lower for Black patients compared to their non‐Black counterparts, in addition to those with lower‐stage cancers, higher physical function, and lower supportive care service utilization. While this disparity in outcomes based on race seems surprising given the overall increased mortality for Black individuals, 39 , 40 some evidence suggests that rates of death from cancer for Black individuals are decreasing. 41 Specifically, studies of prostate cancer and lung cancer outcomes, the two most prominent cancers in this sample, identified that Black patients had a lower risk of death compared to whites. 42 , 43 , 44 Yet, stage of cancer, SES including educational attainment, health co‐morbidities, and other sociodemographics may be more predictive of mortality than race, therefore confounding the results of this analysis. 45 , 46 , 47 Contrary to previous findings, supportive care service utilization, while high, was also related to increased mortality. 48 It may be that Veterans in this sample who used supportive care services were more ill and older, especially compared to other samples and evidenced by a large proportion having advanced‐stage disease and high rates of mortality within 18 months of screening, where supportive care services may have less of a clinical impact on mortality. 49 All supportive care services are also not created equal, and due to the lack of statistical power, we were unable to evaluate the relative impact of each service on mortality. Future research is required to understand how the types and variety of input from different supportive care services could be mediating any subsequent changes in distress outcomes. The mean age of this cohort was 72 years old, and there existed a consistent significant relationship between those who were more physically active having lower rates of supportive care service utilization, hospitalizations, and mortality. These findings support the strong relationship between age, physical function, and relevant cancer outcomes.
To our knowledge, few studies evaluating interdisciplinary distress screening programs and related healthcare utilization and mortality exist among Veterans. This study has several limitations. No comparison group existed to evaluate differences between those who engaged in the screening program and those did not, or reasons for lack of screening, and we did not control for clinic differences in our analyses. Future studies comparing outcomes between groups may identify particular benefits of screening. Additionally, given limitations in the medical record, we were unable to confirm that supportive care service utilization was a direct result of screening and referral from the program. However, few patients prior to distress screening were receiving supportive care services. Findings of this study may be generalizable only to similar samples of male veterans from underserved communities; few individuals were female (around 4%) and many cancers were unstaged (e.g., prostate and blood). Female veterans face unique challenges that may vary from their male counterparts, particularly within the cancer context, and should therefore be evaluated in future studies. Lastly, findings from VA hospitals may not be generalizable to non‐VA centers; however, previous comparisons between VA and fee‐for‐service Medicare services indicated that VA cancer care may be either equal or better than Medicare counterparts. 50
In conclusion, care models that are integrated within oncology to identify and treat supportive care needs can successfully result in increased care integration that likely improves quality of life and reduces cancer burden for underserved patients and health care systems alike. Individuals with elevated distress needs and who report lower physical function will utilize more supportive care services and have higher rates of hospitalizations during cancer; those who are more active, Black, have lower stage cancer, and use less supportive care services may have lower odds of mortality.
AUTHOR CONTRIBUTIONS
Matthew J. Allsop: Methodology (equal); writing – original draft (supporting); writing – review and editing (supporting). Subrina Farah: Formal analysis (lead); methodology (supporting); writing – review and editing (equal). Farah Salim: Data curation (equal); project administration (supporting); writing – review and editing (supporting). Joshua Hauser: Conceptualization (supporting); funding acquisition (equal); project administration (supporting); resources (lead); writing – review and editing (supporting). Ashton R. Baltazar: Writing – review and editing (supporting). Robert E Molokie: Conceptualization (supporting); data curation (supporting); project administration (supporting); resources (supporting); writing – review and editing (supporting). Jane Weber: Data curation (supporting); resources (supporting); writing – review and editing (supporting). Christine Brezina Weldon: Conceptualization (equal); methodology (supporting); project administration (equal); writing – review and editing (supporting). Lawrence Feldman: Data curation (supporting); project administration (supporting); writing – review and editing (supporting). Joanna Martin: Conceptualization (equal); data curation (equal); funding acquisition (lead); project administration (equal); resources (equal); writing – original draft (supporting); writing – review and editing (supporting).
FUNDING INFORMATION
Coleman Foundation (JM, DRA, JH, LF), National Palliative Care Research Center (DRA).
CONFLICT OF INTEREST
The authors have no disclosures to report.
Supporting information
Appendix A.
ACKNOWLEDGMENTS
The authors would like to thank the participants for engaging in this work.
Azizoddin DR, Allsop M, Farah S, et al. Oncology distress screening within predominately Black Veterans: Outcomes on supportive care utilization, hospitalizations, and mortality. Cancer Med. 2023;12:8629‐8638. doi: 10.1002/cam4.5560
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
REFERENCES
- 1. Carlson LE, Zelinski EL, Toivonen KI, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. J Psychosoc Oncol. 2019;37:5‐21. [DOI] [PubMed] [Google Scholar]
- 2. Barbera L, Atzema C, Sutradhar R, et al. Do patient‐reported symptoms predict emergency department visits in cancer patients? A population‐based analysis. Ann Emerg Med. 2013;61:427‐437.e5. [DOI] [PubMed] [Google Scholar]
- 3. Hamilton J, Kroska EB. Distress predicts utilization of psychosocial health services in oncology patients. Psychooncology. 2019;28:61‐67. [DOI] [PubMed] [Google Scholar]
- 4. van Ryn M, Phelan SM, Arora NK, et al. Patient‐reported quality of supportive care among patients with colorectal cancer in the veterans affairs health care system. J Clin Oncol. 2014;32(8):809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Affairs UDoV . Veterans' Diseases Associated with Agent Orange. U.S. Department of Veteran's Affairs; 2010. [Google Scholar]
- 6. Hwa KJ, Dua MM, Wren SM, Visser BC. Missing the obvious: psychosocial obstacles in veterans with hepatocellular carcinoma. HPB. 2015;17:1124‐1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med. 2008;23:654‐671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Funk R, Cisneros C, Williams RC, Kendall J, Hamann HA. What happens after distress screening? Patterns of supportive care service utilization among oncology patients identified through a systematic screening protocol. Support Care Cancer. 2016;24:2861‐2868. [DOI] [PubMed] [Google Scholar]
- 9. Cimino T, Said K, Safier L, Harris H, Kinderman A. Psychosocial distress among oncology patients in the safety net. Psychooncology. 2020;29:1927‐1935. [DOI] [PubMed] [Google Scholar]
- 10. Azizoddin DR, Lakin JR, Hauser J, et al. Meeting the guidelines: implementing a distress screening intervention for veterans with cancer. Psychooncology. 2020;29:2067‐2074. [DOI] [PubMed] [Google Scholar]
- 11. Mack DS, Hunnicutt JN, Jesdale BM, Lapane K. Non‐Hispanic Black‐white disparities in pain and pain management among newly admitted nursing home residents with cancer. J Pain Res. 2018;11:753‐761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ehlers SL, Davis K, Bluethmann SM, et al. Screening for psychosocial distress among patients with cancer: implications for clinical practice, healthcare policy, and dissemination to enhance cancer survivorship. Transl Behav Med. 2019;9:282‐291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Smith SK, Loscalzo M, Mayer C, et al. Best practices in oncology distress management: beyond the screen. Am Soc Clin Oncol Educ Book. 2018;38:813‐821. [DOI] [PubMed] [Google Scholar]
- 14. Network NCC . NCCN Guidelines for Patients–Distress during Cancer Care. National Comprehensive Cancer Network Foundation; 2020. [Google Scholar]
- 15. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32:1605‐1619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Holland JC, Andersen B, Breitbart WS, et al. NCCN: distress management. J Natl Compr Canc Netw. 2007;5:66‐98. [PubMed] [Google Scholar]
- 17. Knies AK, Jutagir DR, Ercolano E, Pasacreta N, Lazenby M, McCorkle R. Barriers and facilitators to implementing the commission on cancer's distress screening program standard. Palliat Support Care. 2019;17:253‐261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Dudgeon D, King S, Howell D, et al. Cancer care Ontario's experience with implementation of routine physical and psychological symptom distress screening. Psychooncology. 2012;21:357‐364. [DOI] [PubMed] [Google Scholar]
- 19. Ercolano E, Hoffman E, Tan H, et al. Managing psychosocial distress: lessons learned in optimizing screening program implementation. Oncology (Williston Park). 2018;32(10):488‐490. [PMC free article] [PubMed] [Google Scholar]
- 20. Lazenby M, Ercolano E, Grant M, Holland JC, Jacobsen PB, McCorkle R. Supporting commission on cancer‐mandated psychosocial distress screening with implementation strategies. J Oncol Pract. 2015;11:e413‐e420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Sutradhar R, Rostami M, Barbera L. Patient‐reported symptoms improve performance of risk prediction models for emergency department visits among patients with cancer: a population‐wide study in Ontario using administrative data. J Pain Symptom Manage. 2019;58:745‐755. [DOI] [PubMed] [Google Scholar]
- 22. Zebrack B, Kayser K, Sundstrom L, et al. Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability. J Clin Oncol. 2015;33:1165‐1170. [DOI] [PubMed] [Google Scholar]
- 23. Mehnert A, Hartung TJ, Friedrich M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology. 2018;27:75‐82. [DOI] [PubMed] [Google Scholar]
- 24. Zebrack B, Kayser K, Bybee D, et al. A practice‐based evaluation of distress screening protocol adherence and medical service utilization. J Natl Compr Canc Netw. 2017;15:903‐912. [DOI] [PubMed] [Google Scholar]
- 25. Acquati C, Kayser K. Addressing the psychosocial needs of cancer patients: a retrospective analysis of a distress screening and management protocol in clinical care. J Psychosoc Oncol. 2019;37:287‐300. [DOI] [PubMed] [Google Scholar]
- 26. Hui D, Titus A, Curtis T, et al. Implementation of the Edmonton symptom assessment system for symptom distress screening at a community cancer center: a pilot program. Oncologist. 2017;22:995‐1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Martin JL, Azizoddin DR, Rynar LZ, et al. Comprehensive and equitable care for vulnerable veterans with integrated palliative, psychology, and oncology care. Fed Pract. 2021;38:S28‐S35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Coleman TF. Supportive Oncology Collaborative. The Coleman Foundation; 2018. [Google Scholar]
- 29. Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (standards for QUality improvement reporting excellence): revised publication guidelines from a detailed consensus process. J Contin Educ Nurs. 2015;46:501‐507. [DOI] [PubMed] [Google Scholar]
- 30. Mitchell AJ. Screening for cancer‐related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013;52:216‐224. [DOI] [PubMed] [Google Scholar]
- 31. Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw. 2013;11:190‐209. [DOI] [PubMed] [Google Scholar]
- 32. Cella D, Yount S, Rothrock N, et al. The patient‐reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45:S3‐S11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Kaiser MJ, Bauer JM, Ramsch C, et al. Validation of the mini nutritional assessment short‐form (MNA®‐SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13:782‐788. [DOI] [PubMed] [Google Scholar]
- 34. Kroenke K, Spitzer RL, Williams JBW, Löwe B. An ultra‐brief screening scale for anxiety and depression: the PHQ‐4. Psychosomatics. 2009;50:613‐621. [DOI] [PubMed] [Google Scholar]
- 35. Weis J, Hönig K, Bergelt C, et al. Psychosocial distress and utilization of professional psychological care in cancer patients: an observational study in National Comprehensive Cancer Centers (CCCs) in Germany. Psychooncology. 2018;27:2847‐2854. [DOI] [PubMed] [Google Scholar]
- 36. Pascoe S, Edelman S, Kidman A. Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. Aust NZJ Psychiatry. 2000;34:785‐791. [DOI] [PubMed] [Google Scholar]
- 37. Fine MJ, Demakis JG. The veterans health administration's promotion of health equity for racial and ethnic minorities. Am J Public Health. 2003;93:1622‐1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chino F, Zafar SY. Financial toxicity and equitable access to clinical trials. Am Soc Clin Oncol Educ Book. 2019;39:11‐18. [DOI] [PubMed] [Google Scholar]
- 39. Hunt BR, Hurlbert MS. Black:white disparities in breast cancer mortality in the 50 largest cities in the United States, 2005–2014. Cancer Epidemiol. 2016;45:169‐173. [DOI] [PubMed] [Google Scholar]
- 40. Babatunde OA, Eberth JM, Felder T, et al. Social determinants of racial disparities in breast cancer mortality among Black and White women. J Racial Ethn Health Disparities. 2021;8:147‐156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212‐236. [DOI] [PubMed] [Google Scholar]
- 42. Halabi S, Dutta S, Tangen CM, et al. Overall survival of Black and White men with metastatic castration‐resistant prostate cancer treated with docetaxel. J Clin Oncol. 2019;37:403‐410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Sartor O, Armstrong AJ, Ahaghotu C, et al. Survival of African‐American and Caucasian men after sipuleucel‐T immunotherapy: outcomes from the PROCEED registry. Prostate Cancer Prostatic Dis. 2020;23:517‐526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Ganti AK, Subbiah SP, Kessinger A, Gonsalves WI, Silberstein PT, Loberiza FR Jr. Association between race and survival of patients with non–small‐cell lung cancer in the United States veterans affairs population. Clin Lung Cancer. 2014;15:152‐158. [DOI] [PubMed] [Google Scholar]
- 45. Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of cancer registries patterns of care study. Cancer. 2008;113:582‐591. [DOI] [PubMed] [Google Scholar]
- 46. Paull DE, Updyke GM, Baumann MA, Chin HW, Little AG, Adebonojo SA. Alcohol abuse predicts progression of disease and death in patients with lung cancer. Ann Thorac Surg. 2005;80:1033‐1039. [DOI] [PubMed] [Google Scholar]
- 47. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Nat Cancer Inst. 2007;99:1384‐1394. [DOI] [PubMed] [Google Scholar]
- 48. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non‐small‐cell lung cancer. N Engl J Med. 2010;363:733‐742. [DOI] [PubMed] [Google Scholar]
- 49. Agha Z, Lofgren RP, VanRuiswyk JV, et al. Are patients at veterans affairs medical centers sicker?: a comparative analysis of health status and medical resource use. Arch Intern Med. 2000;160:3252‐3257. [DOI] [PubMed] [Google Scholar]
- 50. Keating NL, Landrum MB, Lamont EB, et al. Quality of care for older patients with cancer in the veterans health administration versus the private sector: a cohort study. Ann Intern Med. 2011;154:727‐736. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Appendix A.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
